Antimicrobial resistance (AMR) presents a global public health threat, endangering the progress of healthcare worldwide. A key strategic approach for mitigating risks and consequences of AMR is the enhancement of pathogen submission rates prior to antimicrobial therapy in medical institutions.
A study performed at the Department of Hospital Infection Management, Affiliated Jinhua Hospital, Zhejiang University…
Klebsiella pneumoniae, a significant causative agent of community-acquired and nosocomial infections, is contributing to soaring morbidity and mortality rates. The problem is particularly pressing as rising antimicrobial resistance amongst K. pneumoniae strains continues to undermine effective treatment approaches. The situation calls for a thorough analysis and evaluation of initial antimicrobial therapies, 30-day all-cause mortality rates,…
The Menace of Non-Ventilator Hospital-Acquired Pneumonia: Evaluating Impact and Proactive Strategies
Hospital-acquired infections (HAIs) have long posed significant challenges in healthcare settings, despite rigorous federal initiatives aimed at reducing them. Some of the commonly focused HAIs include catheter-associated urinary tract infections (CAUTIs), central line-associated bloodstream infections (CLABSIs), Clostridioides difficile infections (CDI), surgical site infections (SSIs) specific to colon surgeries and abdominal hysterectomies, and methicillin-resistant Staphylococcus aureus…
Recently, a commentary by Dr. Amesh Adalja in MedPage Today argued that treating COVID-19 similarly to other respiratory viruses is a flawed approach given the virus's broader effects on multiple organ systems. This viewpoint challenges the conventional understanding of COVID-19, highlighting the need for a nuanced strategy in managing the virus. Unlike respiratory syncytial virus…